Physician profile
Robert Wayne Baker
NPI 1689225427
$6,835.93
in general payments reported to CMS, 2019-2025
15 companies · $1,858 in 2025
The $1,858 reported for 2025 was more than what 91% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,656 · 2023: $1,519 · 2024: $1,803 · 2025: $1,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,174 · Education: $6.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,173.89 |
| Education | $6.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,770.93 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $1,562.07 | 2022-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $1,291.03 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $620.93 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Alpha Cognition USA, INC. | $527.65 | 2025 | Zunveyl |
| E.R. Squibb & Sons, L.L.C. | $346.95 | 2024-2025 | Cobenfy |
| Lundbeck LLC | $251.99 | 2024-2025 | Rexulti |
| Alkermes, INC. | $127.93 | 2022-2023 | Lybalvi |
| Axsome Therapeutics, INC. | $120.99 | 2024 | Auvelity |
| Harmony Biosciences LLC | $89.51 | 2022 | |
| Shionogi INC | $28.42 | 2022 | |
| Indivior INC. | $27.63 | 2023 | Perseris |
| Regeneron Healthcare Solutions, INC. | $23.49 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.30 | 2022 | |
| Jazz Pharmaceuticals INC. | $23.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.